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A B S T R A C T
This study aimed to estimate the number of incident cases and hospital admissions attributable to secondhand smoke
(SHS) exposure at home for asthma, otitis media (OM), and lower respiratory infections (LRI) in children in Spain.
The burden of respiratory disease caused by SHS exposure was estimated in terms of incident cases and hospitalized
cases for asthma, OM, and LRI. Estimates were calculated using the population attributable fraction. The age-specific
(0-1 year, 0-4 years, 5-11 years, and 0-11 years) prevalence of SHS exposure in children was estimated through a
telephone survey performed in a representative sample of Spanish households with children in 2016. The risk es-
timates for all diseases were selected from international meta-analyses. The number of hospitalized cases was ob-
tained for each disease from the Hospital Minimum Data Set provided by the Ministry of Health of Spain. Incident
cases were obtained from the Global Health Data Exchange. In 2015, SHS exposure caused an estimated total of
136,403 incident cases of the following respiratory diseases: 9058 (8.5%) cases of asthma, 120,248 (8.5%) of OM,
and 7097 (13.5%) of LRI in children aged 0–14 years old in Spain. Likewise, SHS exposure caused a total of 3028
hospitalized cases, with 379 (8.5%) for asthma and 167 (8.5%) for OM in children 0–11 years old, and 2482 (11.6%)
for LRI in children<2 years old. The high burden of respiratory disease attributed to SHS exposure supports the need
to improve protection of children against SHS exposure by extending smoke-free regulations to homes and cars.
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Secondhand smoke (SHS) exposure has been comprehensively as-
sociated with adverse health effects, especially on the cardiovascular
and respiratory systems (Öberg et al., 2010). Children are particularly
vulnerable to the detrimental health effects of SHS, mainly due to their
less developed immune and respiratory systems and their faster
breathing rate (Kerem, 1996), among other factors. Additionally,
younger children are usually very close to the source of SHS on account
of their tendency to be held or to sit on their parents' laps (López and
Continente, 2016). In children, SHS exposure has been causally asso-
ciated with asthma, lower respiratory infections (LRI), otitis media
(OM), sudden infant death syndrome, and low birth weight, among
other conditions (Office on Smoking and Health (US), 2006).
Smoke-free policies have been progressively introduced worldwide
since the application of the World Health Organization Framework
Convention on Tobacco Control (2003) to protect people from SHS. In
Spain, a partial smoke-free law was implemented in 2006 (Law 28/
2005) (López, 2010; BOE, 2005), which was subsequently modified and
became more restrictive in 2011 (Law 42/2010) (BOE, 2010). The in-
troduction of smoke-free laws reduced SHS exposure in venues directly
affected by the law (enclosed workplaces, public places, and hospitality
venues) as well as in unregulated settings, such as homes (Fernández
et al., 2017). After Law 42/2010 came into effect, a study found a 2%
reduction in the proportion of Spanish households with smokers
(García-Villar and López-Nicolás, 2015). However, homes are still one
of the main sources of SHS exposure among children (López et al.,
2018), who are highly exposed whenever there are smokers in the fa-
mily (Arechavala et al., 2018a).
Worldwide, 603,000 deaths were attributed to SHS exposure in
2004, including 166,221 deaths among children younger than 15 years
old (Öberg et al., 2011). The number of deaths caused by LRI attribu-
table to SHS exposure among children younger than 5 years old was the
second largest (165,000) after ischemic heart disease deaths in adults
(379,000). In Europe, 6245 deaths caused by LRI were attributable to
SHS (Öberg et al., 2011). In children, estimates of the burden of disease
in terms of mortality and disability-adjusted life years lost attributable
to SHS have been published in countries such as the United Kingdom
(The Royal College of Physicians, 2010), Poland (Jarosińska et al.,
2014), Canada (Simons et al., 2011), and New Zealand (Mason, 2016).
These studies have mostly focused on asthma, LRI, and OM.
In Spain, mortality in adults due to SHS-related causes was esti-
mated before (López et al., 2007) and after (López et al., 2016) the
introduction of the smoke-free law. However, to the best of our
knowledge, studies assessing the burden of SHS-related diseases attri-
butable to SHS exposure in children in Spain are scarce, and none has
focused on incident cases and hospital admissions. The objective of this
study was to estimate the number of incident cases and hospital ad-
missions attributable to SHS exposure at home for asthma, OM, and LRI
in children in Spain.
2. Methods
2.1. Exposure to secondhand smoke
Data on the prevalence of SHS exposure in children were obtained
from a telephone survey administered in 2016 to a representative
sample of 2411 Spanish households with children younger than
12 years old (López et al., 2018). Households were randomly selected
considering different strata according to geographical region, size of
municipality of residence and quota of sex and age of the youngest child
living at home. The questionnaire gathered specific and extensive in-
formation related to SHS exposure in different settings and was ad-
ministered to parents or legal tutors through landlines and mobile
phones. Exposure to SHS at home was defined by the existence of at
least one smoker among household members at the time of the
interview, which has been widely used in studies analyzing the asso-
ciation between SHS exposure and health outcomes (The Royal College
of Physicians, 2010; Jones et al., 2012, 2011; Burke et al., 2012). The
prevalence of exposure was calculated for boys and girls separately and
for different age groups: 0 to 1 years old, 0 to 4 years old, 5 to 11 years
old, and 0 to 11 years old.
2.2. Health outcomes and risk estimates
The health outcomes selected where those with sufficient and strong
evidence to be causally linked to SHS exposure and with information
about incidence and hospitalizations available for Spain in 2015. The
health outcomes analyzed were asthma, OM and LRI, which includes
bronchitis, bronchiolitis, and other LRI diseases. All measures were
estimated for the year 2015. Risk estimates of disease from SHS ex-
posure were selected from previous meta-analyses (Jones et al., 2012;
Jones et al., 2011; Tinuoye et al., 2013), which showed consistent
evidence of causality between SHS exposure and the health outcomes
studied (Table 1).
Incident cases were estimated through complex mathematical
models using different information sources according to data avail-
ability in each country by the Global Health Data Exchange (GHDx)
(Global Burden of Disease Study 2015, 2016) and were defined as the
number of new cases of a given disease during the year of the study. We
selected figures referring to incident cases of asthma, OM, and LRI in
2015 among children aged 0 to 14 years old in Spain, stratifying by sex
and age groups (0–4 years old for all diseases and 5–14 years old for
asthma and OM). The codes used to define each health outcome were
those used by the GHDx for the incidence of nonfatal diseases (Global
Burden of Disease Study 2015, 2015): 1) asthma included diseases with
tenth Revision of International Classification of Diseases (ICD-10) codes
J45-J45.5 and J45.8-J45.9; 2) OM included diseases with ICD-10 codes
H65-H65.4 and H66-H66.2; and 3) LRI included diseases with ICD-10
codes A48.1, J10-J10.2, J10.8-J10.9, J11-J11.2, J11.8, J12-J12.3,
J12.8-J12.9, J15-J15.9, J16.0, J16.8, J17-J17.3, J17.8, J18-J18.2,
J18.8-J18.9, J20-J20.9, J21-J21.1, J21.8-J21.9, J85.1, P23-P23.6, and
P23.8-P23.9.
Hospitalizations were obtained from the Hospital Minimum Data
Set (MDS) provided by the Ministry of Health, Social Services and
Equality of Spain. The database gathers individual information on the
main and secondary diagnosis by physicians in all Spanish hospitals. We
subsequently selected the number of cases hospitalized, which was
defined as those children aged 0 to 11 years old who had been admitted
at least once to a hospital with the selected health outcomes (asthma,
OM, bronchitis, bronchiolitis, and LRI) as the main admission diagnosis
in 2015 in Spain. The number of cases with any hospitalization was
calculated according to sex and age groups depending on the health
outcome (0–4 years and 5–11 years old for asthma and OM; 0–1 year
old for bronchitis, bronchiolitis and LRI). The codes used to define each
health outcome were selected according to those employed in studies
included in the meta-analysis used in the present study for risk esti-
mates. The ICD-9-CM codes included for each health outcome were as
follows: 1) asthma: code 493; 2) OM: codes 381.0–381.4 and 382; 3)
bronchitis: codes 466.0, 490, and 491.22; 4) bronchiolitis: codes 466.11
and 466.19; and 5) LRI: 073.0, 079.8, 466, 480–488, 490, 491.22,
513.0, and 770.0.
2.3. Estimation of burden of disease
The burden of respiratory disease (for asthma, OM, bronchitis,
bronchiolitis, and LRI) attributable to SHS exposure was estimated by
multiplying the population attributable fraction (PAF) to SHS by the
total burden of these diseases in terms of incident cases and hospitalized
cases.
The PAF, which is the proportion of a health outcome attributable to
a specific risk factor, was calculated by applying the classic
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epidemiological formula (Szklo and Nieto, 2014):
= × × +PAF (P (OR 1))/(P (OR 1) 1)SHS SHS SHS
where PSHS is the prevalence of children exposed to SHS and OR refers
to the odds ratio of morbidity related to SHS exposure. The PAF and the
total burden of disease attributable to SHS was calculated by sex and
age groups for each health outcome.
2.4. Sensitivity analysis
We conducted a sensitivity analysis including alternative assump-
tions to assess different scenarios. Incident cases attributable to SHS
were assessed according to the following alternative assumptions: 1)
defining SHS exposure at home as any household member usually
smoking inside the home (excluding outside areas such as balconies or
terraces); 2) defining SHS exposure at home as any household member
usually smoking either inside or outside (i.e., balcony, terrace) the
home; 3) defining SHS exposure as overall exposure in both private and
public settings; 4) using the lower 95% confidence interval (CI) of OR
estimates and prevalence of SHS exposure; and 5) using the upper
95%CI of OR estimates and prevalence of SHS exposure. For hospita-
lizations, we also tested the following assumptions: 6) for asthma, using
the risk rate of hospital admissions due to asthma exacerbation on the
basis of another recent meta-analysis (Wang et al., 2015); and 7) con-
sidering the main diagnosis and subsequent diagnosis as the cause of
the hospitalizations for each disease.
All sensitivity analyses were conducted for asthma, OM, and LRI
without considering sex and age groups. The effect of changing as-
sumptions is presented in terms of both absolute and percentage
changes in the number of incident cases and hospitalized cases attri-
butable to SHS with respect to the baseline assumption.
3. Results
In 2015, SHS exposure caused an estimated total of 136,403 in-
cident cases (65,860 cases in boys and 70,552 in girls) of the following
respiratory conditions: 9058 of asthma, 120,248 of OM, and 7097 of
LRI in children aged 0 to 14 years old in Spain. The largest number of
cases attributed to SHS exposure was caused by OM (120,248). In
children 0 to 4 years old, 73,194 incident cases of OM, 7097 of LRI, and
3560 of asthma were attributed to SHS exposure. In children 5 to
14 years old, this number was lower for OM (46647) and was higher for
asthma (5498). SHS exposure caused 57,326 incident cases of OM, 4159
of LRI and 4375 of asthma in boys. In girls, these numbers were 62,922,
2948 and 4682, respectively (Table 2).
In terms of hospitalizations in 2015, SHS exposure caused 3028
cases with at least 1 hospitalization due to asthma, OM, or any LRI. In
children 0 to 11 years old, a total of 379 cases hospitalized due to
asthma and 167 due to OM were attributable to SHS exposure. For both
health outcomes, the number of cases hospitalized was slightly higher
in children aged 0 to 4 years old (206 in asthma and 103 in OM) and
among boys (235 and 97, respectively). An estimated 2482 cases of
hospitalization due to LRI (1493 in boys and 998 in girls) were attrib-
uted to SHS exposure in infants 0 to 1 years old. When bronchiolitis was
analyzed separately from other LRI, SHS exposure was responsible for
an estimated 4036 of hospitalized cases, this number being 2415 in
boys and 1634 in girls (Table 3).
Estimates obtained from sensitivity analyses are shown in Table 4.
When we used a more restrictive definition of SHS exposure (based on
reporting smoking inside the home), incident cases attributable to SHS
exposure decreased to 38,117 (a 72% decrease). On the other hand,
when we assumed an overall SHS exposure including different private
and public settings, the total number of incident cases increased to
299,239. When we used the lower and upper limits of the 95%CI of OR
and prevalence of SHS exposure, the total number of incident cases
ranged from 89,272 to 184,512. For hospitalizations, cases of asthma
ranged from 105 to 831, cases of OM from 46 to 367, and cases of LRI
from 660 to 5463 when we assumed different definitions of SHS ex-
posure and 95%CI of OR and prevalence of SHS exposure. When we
assumed an estimate risk of hospital admissions due to asthma ex-
acerbations instead of the incidence of disease, incident asthma cases
increased to 882 (an increase of 133%). Finally, when we considered
not only the main diagnosis but also secondary diagnosis, SHS exposure
was responsible for 505 cases hospitalized with asthma (an increase of
33.2%), 610 with OM (an increase of 265.3%), and 2782 with LRI (an
increase of 12.1%).
4. Discussion
SHS exposure caused almost 140,000 incident cases of asthma, OM
and LRI in Spanish children in the year 2015. By far the highest number
of incident cases was caused by OM (120,248). Hospitalizations attri-
butable to SHS exposure occurred mostly in infants aged 0–1 years old
and were due to LRI, especially to bronchiolitis (4036).
Smoke-free laws introduced in Spain (Law 28/2005 and Law 42/
2010) have been found to be successful in reducing SHS exposure
(Fernández et al., 2017; López et al., 2013). These laws reduced SHS
exposure not only in the public places covered by their content, but also
in private transport and homes (Fernández et al., 2017; García-Villar
and López-Nicolás, 2015; Sureda et al., 2014). In some regions of Spain,
there are also specific strategies implemented in primary health care
level focused on reducing SHS exposure in children (i.e. smoke-free
childhood in Catalonia). Nevertheless, SHS exposure in homes remains
unacceptably high. In 2016 one out of every 3 children younger than
12 years of age was exposed to SHS at home (López et al., 2018).
Moreover, previous studies have found high nicotine concentrations in
Table 1
Effect estimates for the health outcomes related to SHS in children.
Health outcome Odds ratio
(95%CI)
SHS exposure Age (y) Design of included
studies
Reference
Asthma 1.32 (1.23–1.42) Self-reported SHS or biomarkers (cotinine) <18 y 14 cross-sectional; 2
case-control; 4 cohort
Tinuoye et al., 2013
Otitis media 1.32 (1.20–1.45) Self-reported SHS at home (any household member
smokes)
< 16 y Cross-sectional; case-
control; cohort (38)
Jones et al., 2012
Bronchitis 1.58 (1.27–1.98) Self-reported SHS at home and/or biochemical
validation (any household member smokes)
< 2 y 3 cross-sectional; 4
cohort
Jones et al., 2011
Bronchiolitis 2.51 (1.96–3.21) Self-reported SHS at home and/or biochemical
validation (any household member smokes)
< 2 y 2 cross-sectional; 5
case-control
Jones et al., 2011
Lower respiratory
infection
1.54 (1.40–1.69) Self-reported SHS at home and/or biochemical
validation (any household member smokes)
< 2 y 17 cross-sectional; 11
case-control; 9 cohort
Jones et al., 2011
CI: confidence interval; SHS: secondhand smoke.
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homes with smokers. A study performed in homes with children showed
a median nicotine concentration of 1.04 μg/m3 in the living room and
0.48 μg/m3 in the children's bedroom in homes with smokers who re-
ported smoking inside the home, these values being relevant to child
health (Arechavala et al., 2018a).
There is strong evidence to infer a causal association between SHS
exposure and the occurrence and severity of respiratory diseases in
children (Office on Smoking and Health (US), 2006). Our results
showed that the PAFSHS estimated for OM and asthma ranged from
8.3% to 8.7%, depending on sex and age group. The PAFSHS for LRI
were higher, ranging from 11.1% to 27.6%. The markedly highest
PAFSHS were found for bronchiolitis in infants 0 to 1 years old, which
doubled those obtained for bronchitis and LRI in general. This differ-
ence was mainly due to the stronger causal relationship between SHS
exposure and bronchiolitis (Jones et al., 2011). The risk estimate for LRI
was lower than for bronchiolitis, because the estimate was obtained
from a meta-analysis that included some other LRI (i.e., pneumonia,
acute respiratory infection) along with bronchiolitis, which have been
found to be more weakly associated with SHS exposure.
In our study, SHS exposure was defined as living with at least one
smoker. The use of a more stringent definition of SHS exposure, such as
children living in homes where smoking inside was reported, would
have led to more intensive SHS exposure and therefore more con-
servative criteria to calculate estimates of PAFSHS (a decrease of ap-
proximately 70% according to results found in the sensitivity analysis).
However, most studies analyzing the relationship between SHS ex-
posure and health problems define exposure as reported in the present
study (The Royal College of Physicians, 2010; Jones et al., 2012; Jones
et al., 2011; Burke et al., 2012). On the other hand, we could consider
this assumption as conservative, as we did not analyze global SHS ex-
posure, taking into account exposure in other settings such as private
cars, relatives' households or outdoor settings where children have been
found to be exposed to SHS (López et al., 2018), which could harm their
health. As per our sensitivity analysis, use of global SHS exposure
(71.8%) to calculate the PAFSHS would increase the figures obtained by
120% (around 300,000 incident cases and almost 7000 cases of hos-
pitalized cases).
Mortality due to asthma, OM, and LRI attributable to SHS exposure
among children from countries with similar mortality rates to Spain is
lower than those found in African or Asian countries (Öberg et al.,
2011; Mason, 2016). However, morbidity caused by SHS exposure is
not negligible and calls for further public health awareness. A study
conducted in the United Kingdom estimated PAFSHS and the disease
events caused by SHS exposure at home in children for 2008 and re-
ported PAFSHS (11% of LRI, 7% of middle ear disease and 4–10% of
asthma depending on age) similar to those shown in our study. In terms
of morbidity, that study showed that 20,500 cases of LRI (children<
3 years), 121,400 cases of OM (children 0–16 years), and 15,400 cases
of asthma (children 3–14 years) were attributable to SHS exposure.
After analyzing differences in population size (2-fold higher in the
United Kingdom (The Royal College of Physicians, 2010) than in Spain
(National Statistics Institute, 2016)) and similarities in PAFSHS, these
estimates seem to differ from our results (120,248 for OM and 9058 for
asthma in children 0–14 years and 7097 for LRI in children 0–4 years),
being higher in our study for OM. However, comparisons between the
two studies should be interpreted with caution, due to methodological
differences such as the year when the study was conducted, the age
groups analyzed, sources of data, differences in SHS exposure pre-
valences, disease incidences and differences in the ICD codes used to
classify cases for the studied health outcomes.
Our results show a large number of hospital admissions due to LRI.
Around 2500 hospital admissions could have been prevented by in-
troducing smoke-free rules at home. When we estimated hospitaliza-
tions specifically due to bronchiolitis, this figure increased to> 4000.
An explanation for this huge difference could be that bronchiolitis by
itself is a disease with one of the strongest causal associations with SHS
exposure. As previously stated, when we included other diseases of the
lower respiratory tract in the analysis, the risk estimate of morbidity
Table 2


























N % (95%CI) % n N % (95%CI) % n N % (95%CI) % n
Asthma
0–4 y 21,594 29.4
(25.5–33.6)
8.6 1856 20,598 28.1
(24.2–32.5)
8.3 1699 42,192 28.8
(26.0–31.8)
8.4 3560
5–14 y 29,772 28.9
(25.7–32.3)
8.5 2520 34,370 29.8
(26.5–33.2)
8.7 2992 64,142 29.3
(27.0–31.7)
8.6 5498
All ages 51,366 29.1
(26.6–31.7)
8.5 4375 54,968 29.1
(26.6–31.8)




0–4 y 415,246 29.4
(25.5–33.6)
8.6 35,707 452,162 28.1
(24.2–32.5)
8.3 37,304 867,408 28.8
(26.0–31.8)
8.4 73,194
5–14 y 257,703 28.9
(25.7–32.3)
8.5 21,814 286,470 29.8
(26.5–33.2)
8.7 24,939 544,173 29.3
(27.0–31.7)
8.6 46,647
All ages 672,949 29.1
(26.6–31.7)
8.5 57,326 738,632 29.1
(26.6–31.8)




0–4 y 30,356 29.4
(25.5–33.6)
13.7 4159 22,381 28.1
(24.2–32.5)
13.2 2948 52,737 28.8
(26.0–31.8)
13.5 7097
Totald 44,458 – – 65,860 1,609,581 – – 70,552 77,566 – – 136,403
CI: confidence interval; LRI: lower respiratory infection; PAF: population attributable fraction; SHS: secondhand smoke.
a Totals were calculated directly using specific prevalences of SHS exposure for both girls and boys together. Totals do not exactly sum results for girls and boys.
b Any household member is a smoker. SHS exposure was calculated according to the age groups 0–4 y, 5–11 y and 0–11 y.
c Incident cases attributable to SHS have been calculated using all decimal digits obtained from the PAF classic formula.
d Includes the sum of incident cases of asthma, OM, and LRI attributable to SHS exposure.
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due to SHS exposure for LRI decreased, since the relationship between
SHS and other LRI are weaker. Thus, estimates may change depending
on the diseases classified as LRI in the analysis.
Previous studies (Rayens et al., 2008; Rando-Matos et al., 2017)
have shown a decrease in hospital admissions due to asthma in adults
after the introduction of smoke-free legislation. However, in children,
reductions have been less intense (Rando-Matos et al., 2017). These
discrepancies among adults and children might be due to differences in
SHS exposure settings. Adults might be exposed in settings covered by
smoke-free legislations such as hospitality venues and the workplace
while the main venues of SHS exposure in children are homes and
private cars (Office on Smoking and Health (US), 2006), neither of
which are covered by legislation in most countries, except for some,
such as the United Kingdom, France, Australia, the US, Canada (López
and Continente, 2016), or recently Italy in cars. Our results show fig-
ures for OM (167) and asthma (379) markedly lower than for LRI.
However, when considering the risk of hospital admissions for asthma
exacerbations in the sensitivity analysis, morbidity attributable to
hospitalizations due to asthma (Wang et al., 2015), which are probably
due to more severe asthma exacerbations, increased by 133% to a total
of 882 cases. Therefore, these figures should not be disregarded since
they are not trivial and might represent high health costs for children
and economic costs for healthcare services (Batscheider et al., 2012).
This study has intrinsic limitations. First, we estimated the number
of incident cases and hospitalized cases caused by past SHS exposure by
using the most recent year (2016) exposure figures. However, since
most children involved in this study were born after the introduction of
smoke-free laws, the prevalence of SHS exposure would not have
differed much from then onward. Children born before the law came
into effect may have been exposed to higher levels of SHS, and conse-
quently we may have underestimated the number of incident cases and
hospitalizations attributable to SHS exposure. Additionally, SHS ex-
posure was defined on the basis of self-reported information, which
may generate information bias. However, self-reported SHS exposure
has been proven to have good validity (Arechavala et al., 2018b).
Moreover, the indicator used was the number of smokers at home,
which should not be that sensitive to this type of bias. Second, our
estimates are not based on relative risks for SHS exposure from the
Spanish population, due to a lack of local and national evidence.
Moreover, risk estimates used in this study did not take into con-
sideration some potential confounding factors such as indoor or out-
door pollution. Nevertheless, we obtained risks estimates from meta-
analyses, pooling data from different countries, used in previous studies
to determine the burden of respiratory disease attributable to SHS ex-
posure in other countries (Jarosińska et al., 2014), which also made our
results comparable with those of other published studies. Third, the
number of incident cases for all diseases was not obtained from mi-
crodata, but from estimates published in the GHDx website, which
hampers the acquisition of further information about what this measure
takes into account. However, incidence data for the diseases studied are
not available in Spain. Finally, we analyzed heterogeneus age groups,
depending on the health outcome, the measure studied, and the in-
formation source used. Thus, the prevalence of SHS exposure was cal-
culated for children 0 to 11 years old, while data on incident cases were
for children 0 to 14, since incident cases were obtained from aggregated
data published in specific age groups instead of microdata;
Table 3


































N % (95%CI) % n N % (95%CI) % n N % (95%CI) % n
Asthma
0–4 y 1563 29.4
(25.5–33.6)
8.6 134 888 28.1
(24.2–32.5)
8.3 73 2451 28.8
(26.0–31.8)
8.4 206
5–11 y 1202 28.9
(25.7–32.3)
8.5 101 798 29.8
(26.5–33.2)
8.7 69 2000 29.3
(27.0–31.7)
8.7 171
All ages 2765 29.1
(26.6–31.7)
8.5 235 1686 29.1
(26.6–31.8)




0–4 y 731 29.4
(25.5–33.6)
8.6 62 495 28.1
(24.2–32.5)
8.3 40 1226 28.8
(26.0–31.8)
8.4 103
5–11 y 418 28.9
(25.7–32.3)
8.5 35 325 29.8
(26.5–33.2)
8.7 28 743 29.3
(27.0–31.7)
8.6 63
All ages 1149 29.1
(26.6–31.7)
8.5 97 820 29.1
(26.6–31.8)




0–1 y 1884 25.3
(19.3–32.4)
12.8 241 1169 23.2
(17.1–30.6)




0–1 y 8738 25.3
(19.3–32.4)
27.6 2415 6301 23.2
(17.1–30.6)




0–1 y 12,427 25.3
(19.3–32.4)
12.0 1493 8970 23.2
(17.1–30.6)
11.1 998 21,397 24.3
(19.9–29.3)
11.6 2482
Totald 30,877 – – 1825 21,452 – – 1210 52,329 – – 3028
CI: confidence interval; LRI: lower respiratory infection; PAF: population attributable fraction; SHS: secondhand smoke.
a Totals were calculated directly using specific prevalences of SHS exposure for both girls and boys together. Totals do not exactly sum results for girls and boys.
b Any household member is a smoker. SHS exposure was calculated according to the age range analyzed.
c Hospitalized cases attributable to SHS have been calculated using all decimal digits obtained from the PAF classic formula.
d Includes the sum of hospitalized cases for asthma, OM, and LRI.
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consequently, we were not able to disaggregate data for different age
groups. The inclusion of children aged 12–14 years old for some dis-
eases might result in an overestimation of attributable incident cases
among this group of age since some of them might already have ever
smoked, and be thus misclassified as passive smokers. Nonetheless, the
mean age of starting tobacco consumption in Spain in 2016 was
14.1 years old (Plan Nacional sobre Drogas, 2018), minimizing thus this
limitation.
To our knowledge, there are no published studies estimating the
burden of respiratory disease attributable to SHS exposure in children
in a southern European country. In addition, we used primary data from
a representative sample of Spanish children to determine the pre-
valence of SHS exposure, which provided specific prevalences of SHS
exposure according to sex and age groups to calculate more reliable
estimates. We also used objective data of hospital admissions from the
MDS to determine cases hospitalized due to the diseases studied, which
allowed us to analyze data aggregated by using suitable age groups.
5. Conclusions
Exposure to SHS at home in 2015 caused about 140,000 incident
cases and 3000 cases hospitalized for preventable respiratory diseases
such as asthma, OM, and LRI in children 0 to 14 years old. This relevant
burden of respiratory disease due to SHS exposure calls for improve-
ments in the protection of children against SHS exposure through the
further implementation of existing legislation and the extension of
smoke-free regulations. Regarding SHS exposure at home, educational
campaigns and counseling about smoking cessation among household
members of families with children or alternatively interventions fo-
cused on promoting smoke-free homes would be needed.
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